Fig. 6From: Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systemsKey points for the delivery of ncRNA-based therapies. An ideal ncRNA-based therapy is: specific, as it targets a specific cell type of interest; stable as it needs to reduce intrinsic ncRNA instability; tolerable, as it must not trigger the host immune response; deliverable, as it must include a suitable delivery vehicle. Figure created with BioRender.com online toolBack to article page